Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2025-12-25 @ 3:46 AM
NCT ID:
NCT06227702
Eligibility Criteria:
Inclusion Criteria:
* Age over 18 years old.
* Hospitalization in ICU for at least 48 hours.
* Patient in septic shock for at least 24 hours and clinically stable defined by mean arterial pressure ≥ 65 mmHg and maximum infusion of 0.20 μg/kg/min of norepinephrine and lactate \< 4.0 mmol/L.
* Signed informed consent
Exclusion Criteria:
* Patients in use of more than one vasopressor
* Known right ventricle dysfunction
* Indication to use furosemide for other reasons
* Hypernatremia (Na \>160 mmol/L)
* Advanced acute kidney injury(KDIGO 3)
* Current renal replacement therapy
* Anuria for ≥ 6 hours
* Hepatorenal syndrome
* Patients in palliative care
* Furosemide allergy.
* Rhabdomyolysis.
* Major burn
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06227702
Study Brief:
Protocol Section:
NCT06227702